At 31 dicember
'19Consolidated balance sheet
Note |
31-12-2019 |
31-12-2018 (*) |
31-12-2017 (*) |
|
|---|---|---|---|---|
Cash and cash balances at central banks and other demand deposits |
15,110 |
19,158 |
20,155 |
|
Financial assets held for trading |
7,370 |
9,810 |
10,597 |
|
Derivatives |
6,194 |
8,707 |
8,162 |
|
Equity instruments |
457 |
348 |
403 |
|
Debt securities |
719 |
755 |
2,032 |
|
Financial assets not designated for trading compulsorily measured at fair value through profit or loss |
427 |
704 |
|
|
Equity instruments |
198 |
232 |
|
|
Debt securities |
63 |
145 |
|
|
Loans and advances |
166 |
327 |
|
|
Customers |
166 |
327 |
|
|
Financial assets designated at fair value through profit or loss |
1 |
|
6,500 |
|
Equity instruments |
|
|
4,299 |
|
Debt securities |
1 |
|
2,101 |
|
Loans and advances |
|
|
100 |
|
Credit institutions |
|
|
100 |
|
Financial assets at fair value with changes in other comprehensive income |
18,371 |
21,888 |
|
|
Equity instruments |
2,407 |
3,565 |
|
|
Debt securities |
15,964 |
18,323 |
|
|
Available-for-sale financial assets |
|
|
69,555 |
|
Equity instruments |
|
|
2,883 |
|
Debt securities |
|
|
66,672 |
|
Financial assets at amortised cost |
244,702 |
242,582 |
|
|
Debt securities |
17,389 |
17,060 |
|
|
Loans and advances |
227,313 |
225,522 |
|
|
Central bankss |
6 |
5 |
|
|
Credit institutions |
5,153 |
7,550 |
|
|
Customers |
222,154 |
217,967 |
|
|
Loans and receivables |
|
|
226,273 |
|
Debt securities |
|
|
2,576 |
|
Loans and advances |
|
|
223,697 |
|
Central banks |
|
|
5 |
|
Credit institutions |
|
|
7,374 |
|
Customers |
|
|
216,318 |
|
Held-to-maturity investments |
|
|
11,085 |
|
Derivatives - Hedge accounting |
2,133 |
2,056 |
2,597 |
|
Fair value changes of the hedged items in portfolio hedge of interest rate risk |
106 |
232 |
11 |
|
Investments in joint ventures and associates |
3,941 |
3,879 |
6,224 |
|
Joint ventures |
166 |
168 |
187 |
|
Associatess |
3,775 |
3,711 |
6,037 |
|
Assets under the insurance business |
72,683 |
61,688 |
275 |
|
Tangible assets |
7,282 |
6,022 |
6,480 |
|
Property, plant and equipment |
4,915 |
3,210 |
3,076 |
|
For own use |
4,915 |
3,210 |
3,076 |
|
Investment property |
2,367 |
2,812 |
3,404 |
|
Intangible assets |
3,839 |
3,848 |
3,805 |
|
Goodwill |
3,051 |
3,051 |
3,051 |
|
Other intangible assets |
788 |
797 |
754 |
|
Tax assets |
11,113 |
11,264 |
11,005 |
|
Current tax assets |
1,277 |
1,223 |
800 |
|
Deferred tax assets |
9,836 |
10,041 |
10,205 |
|
Other assets |
2,982 |
2,176 |
2,505 |
|
Inventories |
54 |
57 |
878 |
|
Remaining other assets |
2,928 |
2,119 |
1,627 |
|
Non-current assets and disposal groups classified as held for sale |
1,354 |
1,239 |
6,069 |
|
Total assets |
|
391,414 |
386,546 |
383,136 |
Memorandum items |
|
|
|
|
Loan commitments given |
71,132 |
63,953 |
61,190 |
|
Financial guarantees given |
5,982 |
5,735 |
6,015 |
|
Other commitments given |
21,226 |
19,339 |
19,461 |
|
Financial instruments loaned or delivered as collateral with the right of sale or pledge |
|
|
|
|
Financial assets held for trading |
165 |
469 |
1,053 |
|
Financial assets at fair value with changes in other comprehensive income |
2,544 |
2,801 |
|
|
Available-for-sale financial assets |
|
|
7,383 |
|
Financial assets at amortised cost |
93,053 |
97,767 |
|
|
Loans and receivables |
|
|
103,155 |
|
Held-to-maturity investments |
|
|
3,600 |
|
Tangible assets acquired under a lease |
1,495 |
|
|
|
(*) Presented for comparison purposes only (see Note 1)
Note |
31-12-2019 |
31-12-2018 (*) |
31-12-2017 (*) |
|
|---|---|---|---|---|
Financial liabilities held for trading |
2,338 |
9,015 |
8,605 |
|
Derivatives |
1,867 |
8,616 |
7,861 |
|
Short positions |
471 |
399 |
744 |
|
Financial liabilities designated at fair value through profit or loss |
1 |
|
8,241 |
|
Deposits |
|
|
8,241 |
|
Customers |
|
|
8,241 |
|
Other financial liabilities |
1 |
|
|
|
Financial liabilities at amortised cost /p> |
283,975 |
282,460 |
280,898 |
|
Deposits |
241,735 |
247,640 |
246,804 |
|
Central banks |
14,418 |
29,406 |
31,681 |
|
Credit institutions |
6,238 |
8,034 |
11,515 |
|
Customers |
221,079 |
210,200 |
203,608 |
|
Debt securities issued |
33,648 |
29,244 |
29,919 |
|
Other financial liabilities |
8,592 |
5,576 |
4,175 |
|
Derivatives - Hedge accounting |
515 |
793 |
793 |
|
Fair value changes of the hedged items in portfolio hedge of interest rate risk |
1,474 |
1,244 |
1,410 |
|
Liabilities under the insurance business |
70,807 |
61,519 |
50,999 |
|
Provisions |
3,624 |
3,079 |
3,491 |
|
Pensions and other post-employment defined benefit obligations |
521 |
458 |
598 |
|
Other long-term employee benefits |
1,710 |
1,072 |
1,223 |
|
Pending legal issues and tax litigation |
676 |
714 |
803 |
|
Commitments and guarantees given |
220 |
355 |
357 |
|
Other provisions |
497 |
480 |
510 |
|
Tax liabilities |
1,296 |
1,351 |
1,416 |
|
Current tax liabilities |
238 |
236 |
194 |
|
Deferred tax liabilities |
1,058 |
1,115 |
1,222 |
|
Other liabilities |
2,162 |
2,639 |
2,335 |
|
Liabilities included in disposal groups classified as held for sale |
71 |
82 |
82 |
|
Total liabilities |
|
366,263 |
362,182 |
358,270 |
Memorandum items |
|
|
|
|
Subordinated liabilities |
|
|
|
|
Financial liabilities at amortised cost |
5,461 |
5,456 |
5,054 |
|
(*) Presented for comparison purposes only (see Note 1)
Note |
31-12-2019 |
31-12-2018 (*) |
31-12-2017 (*) |
|
|---|---|---|---|---|
Shareholders' equity |
26.247 |
25.384 |
24.722 |
|
Capital |
5,981 |
5,981 |
5,981 |
|
Share premium |
12,033 |
12,033 |
12,033 |
|
Other equity items |
24 |
19 |
10 |
|
Retained earnings |
7,795 |
7,300 |
6,038 |
|
Other reserves |
(1,281) |
(1,505) |
(594) |
|
(-) Treasury shares |
(10) |
(10) |
(12) |
|
Profit/(loss) attributable to owners of the Parent |
1,705 |
1,985 |
1,684 |
|
(-) Interim dividends |
|
(419) |
(418) |
|
Accumulated other comprehensive income |
(1,125) |
(1,049) |
(290) |
|
Items that will not be reclassified to profit or loss |
(1,568) |
(1,336) |
(402) |
|
Actuarial gains or (-) losses on defined benefit pension plans |
(474) |
(396) |
(402) |
|
Share of other recognised income and expense of investments in joint ventures and associates |
(83) |
(75) |
|
|
Fair value changes of equity instruments measured at fair value with changes in other comprehensive income |
(1,011) |
(865) |
|
|
Failed fair value hedges of equity instruments measured at fair value with changes in other comprehensive income |
|
|
|
|
Fair value changes of equity instruments measured at fair value with changes other comprehensive income [hedged instrument] |
(58) |
|
|
|
Fair value changes of equity instruments measured at fair value with changes in other comprehensive income [hedging instrument] |
58 |
|
|
|
Items that may be reclassified to profit or loss |
443 |
287 |
112 |
|
Foreign currency exchange |
4 |
2 |
74 |
|
Hedging derivatives. Reserve of cash flow hedges [effective portion] |
(34) |
22 |
16 |
|
Fair value changes of debt securities measured at fair value with changes in other comprehensive income |
486 |
317 |
|
|
Share of other recognised income and expense of investments in joint ventures and associates |
(13) |
(54) |
(29) |
|
Available-for-sale financial assets |
|
|
51 |
|
Debt instruments |
|
|
475 |
|
Equity instruments |
|
|
(424) |
|
Minority interests (non-controlling interests) |
29 |
29 |
434 |
|
Accumulated other comprehensive income |
|
|
(17) |
|
Other items |
29 |
29 |
451 |
|
Total equity |
25,151 |
24,364 |
24,866 |
|
Total liabilities and equity |
391,414 |
386,546 |
383,136 |
|
(*) Presented for comparison purposes only (see Note 1)
Consolidated statement of profit or loss
Note |
31-12-2019 |
31-12-2018 (*) |
31-12-2017 (*) |
|
|---|---|---|---|---|
Interest income |
7,055 |
6,946 |
6,971 |
|
Financial assets at fair value with changes in other comprehensive income (1) |
1,966 |
1,856 |
2,082 |
|
Financial assets at amortised cost (2) |
4,972 |
4,902 |
4,752 |
|
Other interest income |
117 |
188 |
137 |
|
Interest expense |
(2,104) |
(2,039) |
(2,225) |
|
Net interest income |
|
4,951 |
4,907 |
4,746 |
Dividend income |
163 |
146 |
127 |
|
Share of profit/(loss) of entities accounted for using the equity method |
425 |
826 |
526 |
|
Fee and commission income |
2,940 |
2,898 |
2,760 |
|
Fee and commission expenses |
(342) |
(315) |
(261) |
|
Gains/(losses) on derecognition of financial assets and liabilities not measured at fair value through profit or loss, net |
240 |
126 |
169 |
|
Financial assets at amortised cost |
2 |
(25) |
|
|
Other financial assets and liabilities |
238 |
151 |
|
|
Gains/(losses) on financial assets and liabilities held for trading, net |
139 |
40 |
47 |
|
Other gains or losses |
139 |
40 |
|
|
Gains/(losses) on financial assets not designated for trading compulsorily measured at fair value through profit or loss, net |
(74) |
61 |
|
|
Other gains or losses |
(74) |
61 |
|
|
Gains/(losses) from hedge accounting, net |
45 |
39 |
(9) |
|
Exchange differences (gain/loss), net |
(52) |
12 |
76 |
|
Other operating income |
655 |
628 |
698 |
|
Other operating expenses |
(1,041) |
(1,152) |
(1,128) |
|
Income from assets under insurance and reinsurance contracts |
884 |
939 |
823 |
|
Expenses from liabilities under insurance and reinsurance contracts |
(328) |
(388) |
(352) |
|
Gross income |
|
8,605 |
8,767 |
8,222 |
Administrative expenses |
(5,204) |
(4,254) |
(4,150) |
|
Personnel expenses |
(3,956) |
(2,958) |
(2,981) |
|
Other administrative expenses |
(1,248) |
(1,296) |
(1,169) |
|
Depreciation and amortisation |
(546) |
(404) |
(427) |
|
Provisions or reversal of provisions |
(186) |
(441) |
(762) |
|
Impairment/(reversal) of impairment on financial assets not measured at fair value through profit or loss or net profit or loss due to a change |
(425) |
(126) |
(949) |
|
Financial assets at fair value with changes in other comprehensive income |
|
(2) |
|
|
Financial assets at amortised cost |
(425) |
(124) |
|
|
Available-for-sale financial assets |
|
|
(144) |
|
Loans and receivables |
|
|
(805) |
|
Impairment/(reversal) of impairment on investments in joint ventures and associates |
|
(61) |
5 |
|
Impairment/(reversal) of impairment on non-financial assets |
(106) |
(49) |
(170) |
|
Tangible assets |
(80) |
(17) |
(53) |
|
Intangible assets |
(25) |
(25) |
(70) |
|
Other |
(1) |
(7) |
(47) |
|
Gains/(losses) on derecognition of non-financial assets, net |
55 |
(476) |
(115) |
|
Negative goodwill recognised in profit or loss |
|
|
442 |
|
Profit/(loss) from non-current assets and disposal groups classified as held for sale not qualifying as discontinued operations |
(116) |
(149) |
2 |
|
Profit/(loss) before tax from continuing operations |
|
2,077 |
2,807 |
2,098 |
Tax expense or income related to profit or loss from continuing operations |
(369) |
(712) |
(378) |
|
Profit/(loss) after tax from continuing operations |
|
1,708 |
2,095 |
1,720 |
Profit/(loss) after tax from discontinued operations |
|
(55) |
(2) |
|
Profit/(loss) for the period |
|
1,708 |
2,040 |
1,719 |
Attributable to minority interests (non-controlling interests) |
3 |
55 |
35 |
|
Attributable to owners of the parent |
1,705 |
1,985 |
1,684 |
|
(*) Presented for comparison purposes only (see Note 1)
(1) Also includes in 2019 and 2018 the interest on available-for-sale financial assets (IAS 39) linked to the insurance business and in 2017 the interest on available-for-sale financial assets (IAS 39).
(2) Also includes in 2019 and 2018 interest on loans and receivables (IAS 39) of the insurance business and in 2017 interest on loans and receivables (IAS 39).
Consolidated statement of changes in equity
2019 |
2018 (*) |
2017 (*) |
|
|---|---|---|---|
Profit/(loss) for the period |
1,708 |
2,040 |
1,719 |
Other comprehensive income |
(76) |
(715) |
(118) |
Items that will not be reclassified to profit or loss |
(232) |
(517) |
(4) |
Actuarial gains or losses on defined benefit pension plans |
(124) |
(43) |
(6) |
Share of other recognised income and expense of investments in joint ventures and associates |
(8) |
(64) |
|
Fair value changes of equity instruments measured at fair value with changes in other comprehensive income |
(145) |
(455) |
|
Failed fair value hedges of equity instruments measured at fair value with changes in other comprehensive income |
|
|
|
Fair value changes of equity instruments measured at fair value with changes in equity [hedged instrument] |
(58) |
|
|
Fair value changes of equity instruments measured at fair value with changes in equity [hedging instrument] |
58 |
|
|
Income tax relating to items that will not be reclassified |
45 |
45 |
2 |
Items that may be reclassified to profit or loss |
156 |
(198) |
(114) |
Foreign currency exchange |
2 |
(87) |
86 |
Translation gains/(losses) taken to equity |
2 |
(229) |
86 |
Transferred to profit or loss |
|
142 |
|
Cash flow hedges (effective portion) |
(54) |
15 |
1 |
Valuation gains/(losses) taken to equity |
9 |
(60) |
41 |
Transferred to profit or loss |
(63) |
75 |
(40) |
Debt instruments classified as fair value financial assets with changes in other comprehensive income |
325 |
(114) |
|
Valuation gains/(losses) taken to equity |
523 |
7 |
|
Transferred to profit or loss |
(198) |
(121) |
|
Available-for-sale financial assets |
|
|
(64) |
Valuation gains/(losses) taken to equity |
|
|
(111) |
Transferred to profit or loss |
|
|
47 |
Share of other recognised income and expense of investments in joint ventures and associates |
41 |
|
(154) |
Income tax relating to items that may be reclassified to profit or loss |
(158) |
(12) |
17 |
Total comprehensive income for the period |
1,632 |
1,325 |
1,601 |
Attributable to minority interests (non-controlling interests) |
3 |
76 |
61 |
Attributable to owners of the parent |
1,629 |
1,249 |
1,540 |
(*) Presented for comparison purposes only (see Note 1)
Equity attributable to the parent |
Minority interests |
|
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shareholders' equity |
|
|
|||||||||||
Note |
Capital |
Share premium |
Other equity |
retained earnings |
Other reserves |
Less: treasury shares |
Profit/(loss) attributable to the owners of the parent |
Less: interim dividends |
Accumulated other comprehensive income |
Accumulated other comprehensive income |
Other items |
Total |
|
Opening balance at 31-12-2016 |
5,981 |
12,033 |
7 |
5,239 |
(717) |
(14) |
1,047 |
(177) |
127 |
|
29 |
23,555 |
|
Effects of changes in accounting policies |
|
|
|
220 |
233 |
|
|
|
(208) |
|
|
245 |
|
Pension obligations |
|
|
|
220 |
233 |
|
|
|
(208) |
|
|
245 |
|
Balance at 31-12-2016 |
5,981 |
12,033 |
7 |
5.459 |
(484) |
(14) |
1,047 |
(177) |
(81) |
|
29 |
23,800 |
|
Total comprehensive income for the period |
|
|
|
|
|
|
1,684 |
|
(144) |
26 |
35 |
1,601 |
|
Other changes in equity |
|
|
3 |
579 |
(110) |
2 |
(1,047) |
(241) |
(65) |
(43) |
387 |
(535) |
|
Dividends (or remuneration to shareholders) |
|
|
|
(359) |
|
|
|
(418) |
|
|
(1) |
(778) |
|
Purchase of treasury shares |
|
|
|
|
|
|
|
|
|
|
|
(0) |
|
Sale or cancellation of treasury shares |
|
|
|
|
|
2 |
|
|
|
|
|
3 |
|
Transfers among components of equity |
|
|
|
935 |
|
|
(1,047) |
177 |
(65) |
(43) |
42 |
|
|
Other increase/(decrease) in equity |
|
|
3 |
3 |
(110) |
|
|
|
|
|
346 |
240 |
|
Balance at 31-12-2017 |
5,981 |
12,033 |
10 |
6,038 |
(594) |
(12) |
1,684 |
(418) |
(290) |
17 |
451 |
24,866 |
|
Effects of changes in accounting policies |
|
|
|
|
(538) |
|
|
|
(23) |
(4) |
9 |
(556) |
|
First application of IFRS 9 |
|
|
|
|
(538) |
|
|
|
(23) |
(4) |
9 |
(556) |
|
Opening balance at 01-01-2018 |
5,981 |
12,033 |
10 |
6.038 |
(1,132) |
(12) |
1,684 |
(419) |
(313) |
(21) |
460 |
24,309 |
|
Total comprehensive income for the period |
|
|
|
|
|
|
1,985 |
|
(736) |
21 |
55 |
1,325 |
|
Other changes in equity |
|
|
9 |
1,262 |
(373) |
2 |
(1,684) |
|
|
|
(486) |
(1,270) |
|
Dividends (or remuneration to shareholders) |
|
|
|
(478) |
|
|
|
(419) |
|
|
(5) |
(902) |
|
Purchase of treasury shares |
|
|
|
|
|
(2) |
|
|
|
|
|
(2) |
|
Sale or cancellation of treasury shares |
|
|
|
|
|
4 |
|
|
|
|
|
4 |
|
Transfers among components of equity |
|
|
|
1.715 |
|
|
(1.684) |
419 |
|
|
(450) |
|
|
Other increase/(decrease) in equity |
|
|
9 |
25 |
(373) |
|
|
|
|
|
(31) |
(370) |
|
Balance at 31-12-2018 |
5,981 |
12,033 |
19 |
7,300 |
(1,505) |
(10) |
1,985 |
(419) |
(1,049) |
|
29 |
24,364 |
|
Opening balance at 01-01-2019 |
5,981 |
12,033 |
19 |
7,300 |
(1,505) |
(10) |
1,985 |
(419) |
(1,049) |
|
29 |
24,364 |
|
Total comprehensive income for the |
|
|
|
|
|
|
1,705 |
|
(76) |
|
3 |
1,632 |
|
Other changes in equity |
|
|
5 |
495 |
224 |
|
(1,985) |
419 |
|
|
(3) |
(845) |
|
Dividends (or remuneration to shareholders) |
|
|
|
(598) |
|
|
|
|
|
|
(3) |
(601) |
|
Purchase of treasury shares |
|
|
|
|
|
(8) |
|
|
|
|
|
(8) |
|
Sale or cancellation of treasury shares |
|
|
|
|
|
8 |
|
|
|
|
|
8 |
|
Transfers among components of equity |
|
|
|
1,566 |
|
|
(1,985) |
419 |
|
|
|
|
|
Other increase/(decrease) in equity |
|
|
5 |
(473) |
224 |
|
|
|
|
|
|
(244) |
|
Balance at 31-12-2019 |
5,981 |
12,033 |
24 |
7,795 |
(1,281) |
(10) |
1,705 |
|
(1,125) |
|
29 |
25,151 |
|
Consolidated statement of cash flows
Note |
2019 |
2018 (**) |
2017 (**) |
|
|---|---|---|---|---|
A) Cash flows from/(used in) operating activities |
(6,453) |
(4,878) |
6,554 |
|
Profit/(loss) for the period (*) |
1,708 |
2,040 |
1,719 |
|
Adjustments to obtain cash flows from operating activities |
4,495 |
3,518 |
4,501 |
|
Depreciation and amortisation |
546 |
404 |
427 |
|
Other adjustments |
3,949 |
3,114 |
4,074 |
|
Net increase/(decrease) in operating assets |
(8,780) |
(9,438) |
3,312 |
|
Financial assets held for trading |
(1,743) |
(169) |
3,290 |
|
Financial assets not designated for trading compulsorily measured at fair value through profit or loss |
277 |
118 |
0 |
|
Financial assets designated at fair value through profit or loss |
(1) |
0 |
(2,099) |
|
Financial assets at fair value with changes in other comprehensive income |
4,016 |
(1,056) |
0 |
|
Available-for-sale financial assets |
|
0 |
(713) |
|
Financial assets at amortised cost |
(5,879) |
(9,258) |
0 |
|
Loans and receivables |
|
0 |
439 |
|
Other operating assets |
(5,450) |
927 |
2,395 |
|
Net increase/(decrease) in operating liabilities |
(3,787) |
(494) |
(3,132) |
|
Financial liabilities held for trading |
1,333 |
410 |
(1,884) |
|
Financial liabilities designated at fair value through profit or loss |
1 |
0 |
2,264 |
|
Financial liabilities at amortised cost |
(4,687) |
1,996 |
(511) |
|
Other operating liabilities |
(434) |
(2,900) |
(3,001) |
|
Income tax (paid)/received |
(89) |
(504) |
154 |
|
B) Cash flows from/(used in) investing acting activities |
(117) |
5,301 |
(1,378) |
|
Payments: |
(822) |
(1,219) |
(4,056) |
|
Tangible assets |
(525) |
(512) |
(358) |
|
Intangible assets |
(232) |
(224) |
(227) |
|
Investments in joint ventures and associates |
(5) |
(64) |
(32) |
|
Subsidiaries and other business units |
0 |
(354) |
(645) |
|
Non-current assets and liabilities classified as held for sale |
(60) |
(65) |
(31) |
|
Held-to-maturity investments |
|
0 |
(2,763) |
|
Proceeds: |
705 |
6.520 |
2.678 |
|
Tangible assets |
340 |
798 |
153 |
|
Intangible assets |
8 |
5 |
0 |
|
Investments in joint ventures and associates |
9 |
1,302 |
2 |
|
Non-current assets and liabilities classified as held for sale |
348 |
4,415 |
1,173 |
|
Other proceeds related to investing activities |
0 |
0 |
1,350 |
|
C) Cash flows from/(used in) financing activities |
2,521 |
(1,416) |
1,721 |
|
Payments: |
(2,869) |
(8,006) |
(6,157) |
|
Dividends |
(602) |
(902) |
(777) |
|
Subordinated liabilities |
0 |
(2,072) |
(1,302) |
|
Purchase of own equity instruments |
(8) |
(2) |
0 |
|
Other payments related to financing activities |
(2,259) |
(5,030) |
(4,078) |
|
Proceeds: |
5,390 |
6,590 |
7,878 |
|
Subordinated liabilities |
0 |
2,250 |
2,150 |
|
Disposal of own equity instruments |
8 |
4 |
2 |
|
Other proceeds related to financing activities |
5,382 |
4,336 |
5,726 |
|
D) Effect of exchange rate changes |
1 |
(4) |
(2) |
|
E) Net increase/(decrease) in cash and cash equivalents (A+B+C+D) |
(4,048) |
(997) |
6,895 |
|
F) Cash and cash equivalents at beginning of year |
19,158 |
20,155 |
13,260 |
|
G) Cash and cash equivalents at end of the year (E+F) |
15,110 |
19,158 |
20,155 |
|
Cash |
2,700 |
2,468 |
2,177 |
|
Cash equivalents at central banks |
11,836 |
15,783 |
17,092 |
|
Other financial assets |
574 |
907 |
886 |
|
Total cash and cash equivalents at end of year |
15,110 |
19,158 |
20,155 |
|
(*) Of which: Interest received |
7,080 |
7,057 |
7,425 |
|
Of which: Interest paid |
1,951 |
2,100 |
2,404 |
|
Of which: Dividends received |
578 |
456 |
535 |
|
(**) Presented for comparison purposes only.
Notes to the consolidated financial statements
CaixaBank, SA and companies compising the Caixabank Group
As required by current legislation governing the content of consolidated financial statements, these notes to the consolidated financial statements complete, extend and discuss the balance sheet, statement of profit or loss, statement of changes in equity and the statement of cash flows, and form an integral part of them to give a true and fair view of the equity and financial position of the CaixaBank Group at 31 December 2019, and the results of its operations, the changes in equity and the cash flows during the year then ended.
